Invention Grant
- Patent Title: Modified-release dosage forms of 5-HT2C agonists useful for weight management
-
Application No.: US15429221Application Date: 2017-02-10
-
Publication No.: US10226471B2Publication Date: 2019-03-12
- Inventor: Zezhi Jesse Shao , Anthony C. Blackburn , Andrew J. Grottick , Michael E. Morgan , Jaimie Karyn Rueter , Anna Shifrina , Scott Stirn , Libo Yang , Woo Hyun Yoon
- Applicant: Arena Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: Arena Pharmaceuticals, Inc.
- Current Assignee: Arena Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Fish & Richardson P.C.
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/28 ; A61K31/55 ; A61K45/06 ; A61K9/00 ; C07D223/16 ; A61K31/135 ; A61K31/155 ; A23P20/12
Abstract:
The present invention relates to methods for weight management that utilize modified-release dosage forms comprising (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts and crystalline forms thereof. The present invention further relates to (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them.
Public/Granted literature
- US20170246179A1 MODIFIED-RELEASE DOSAGE FORMS OF 5-HT2C AGONISTS USEFUL FOR WEIGHT MANAGEMENT Public/Granted day:2017-08-31
Information query
